Radiologists overestimate their overall risk of malpractice lawsuits in breast imaging

Feb 02, 2009

Radiologists who work in breast imaging tend to overestimate their actual risk of medical malpractice lawsuits, according to a study performed at the University of Washington School of Public Health and Community Medicine in Seattle, WA.

The study included two separate surveys, one in 2002 and one in 2006 that asked radiologists in diverse regions of the US two questions: Have you ever had a previous malpractice claim related to mammography? And what do you think is your future probability of being sued in the next five years? Results showed that "the radiologist's median estimate for the likelihood of being sued was four times higher than their actual risk," said Joann G. Elmore, MD, lead author of the study. In 2002, a radiologist's perceived risk of being sued in the next five years was 41% and in 2006 was 35%. The actual percentage of radiologists who reported malpractice claims five years prior to 2002 was 8% and the actual percentage of radiologists who reported malpractice claims five years prior to the 2006 survey was 10%. "Their perception of risk is much higher than the reported reality," she said.

"Failure to detect breast cancer has been the leading cause of medical malpractice lawsuits. Malpractice litigation has a direct effect on healthcare delivery in the US and ultimately may influence the way we practice medicine," said Dr. Elmore. "Under such circumstances, doctors are turning to defensive medicine, where we order more tests to make certain we aren't missing something," she said.

Workforce shortages in breast imaging may also be considered the result of a physician's perceived risk of malpractice lawsuits. "We have seen fewer residents interested in going into breast imaging, partially because of their perceived risk of being sued," said Dr. Elmore.

This study appears in the February issue of the American Journal of Roentgenology.

Source: American Roentgen Ray Society

Explore further: FTC clears Sun Pharma's $4B purchase of competitor Ranbaxy

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Why aren't there any human doctors in Star Wars?

Jan 30, 2015

Though set "a long time ago in a galaxy far, far away," it isn't hard to see in the Star Wars films a vision of our own not so distant future. But Anthony Jones, a physician with a long background in health ...

Cambodia bans 'virgin surgery' adverts

Jan 29, 2015

The Cambodian government has ordered a hospital to stop advertising so-called virginity restoration procedures, saying it harms the "morality" of society.

What's happening with your donated specimen?

Jan 28, 2015

When donating blood, plasma, human tissue or any other bodily sample for medical research, most people might not think about how it's being used. But if you were told, would you care?

Amgen tops Street 4Q forecasts

Jan 27, 2015

Amgen Inc. cruised to a 27 percent jump in fourth-quarter profit and beat Wall Street expectations, due to higher sales of nearly all its medicines, tight cost controls and a tax benefit.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.